,
After the crackdown, patients on compounded tirzepatide faced three options: (1) transition to branded Zepbound at $1,000+ per month out-of-pocket, (2) switch to compounded semaglutide, which remained legal because Ozempic and Wegovy were still on the FDA shortage list through Q1 2025, or (3) discontinue GLP-1 therapy entirely
The safety of CYANOKIT was studied in animals and healthy people and derived from experience in patients exposed to cyanide
Rotating semaglutide injection sites can help prevent soreness and skin thickening
Treatment of human peripheral lymphocytes with concanavalin A activates expression of glutathione reductase
These drugs have tremendous benefit, but more ongoing studies are needed outside of patients with diabetes, obesity, and metabolic disease before we can apply safely, says Srinath